|
AMRX Amneal Pharmaceuticals Inc 1723128 |
| Balance Sheet |
|
Current Assets
|
$1,797,907,000.00 |
|
Assets
|
$3,540,218,000.00 |
|
Current Liabilities
|
$728,049,000.00 |
|
Equity
|
$-45,411,000.00 |
|
Shares Out
|
319022792.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-26,743,000.00 |
|
Investing Cash Flow
|
$-21,710,000.00 |
| Market Analysis |
Market Cap
|
$5,901,921,652.00 |
|
Price
|
$18.59 |
|
PB
|
12.08 |
|
EPS
|
0.20 |
|
PE
|
46.19 |
|
PS
|
1.89 |
|
FCF
|
$-34,918,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:13 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-27 |
0.21 |
|
| Apr |
May |
Jun |
|
|
2026-04-22 |
0.27 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
0.25 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
0.17 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AMRX documents filed with the SEC.
AMRX Filings
Clear
